These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6654008)

  • 1. [Isolation of therapeutic doses of leukocytes and thrombocytes using a blood cell separator].
    Bláha M; Vanasek J; Malý J; Siroký O; Pecka M
    Gematol Transfuziol; 1983 Oct; 28(10):23-5. PubMed ID: 6654008
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
    Steeper TA; Smith JA; McCullough J
    Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of Haemonetics 30 blood cell separator in transfusiology and other fields of medicine.
    Daszyński J
    Acta Med Pol; 1980; 21(1):93-110. PubMed ID: 7405631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial experiences with routine use of the AS-104 cell separator in a single needle procedure].
    Zeiler T; Weisbach V; Zingsem J; Zimmermann R; Eckstein R
    Beitr Infusionsther; 1993; 31():100-3. PubMed ID: 7693235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of cell separation with new single needle techniques in comparison with a current dual needle technique].
    Moog R; Müller N
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):86-90. PubMed ID: 8019114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative function of centrifugal apheresis devices.
    Rock G; Blanchette V; McCombie N; Tittley P
    Vox Sang; 1985; 48(3):136-42. PubMed ID: 3984299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
    Höcker P; Wagner A; Puffer G; Michl U
    Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
    [No Abstract]   [Full Text] [Related]  

  • 9. Plateletpheresis with the new COBE Spectra.
    Kretschmer V; Rossa W; Eisenhardt G
    Infusionstherapie; 1991 Jun; 18 Suppl 1():24-8. PubMed ID: 1917060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of leukocyte depleted thrombocytapheresis preparations using closed disposable systems with an in-line filter for the AS 104 cell separator].
    Moog R; Kalb R; Müller N; Köbke AC
    Beitr Infusionsther Transfusionsmed; 1997; 34():114-7. PubMed ID: 9417334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donors leukapheresis on Fenwal CS-3000.
    Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E
    Mater Med Pol; 1990; 22(1):33-5. PubMed ID: 2079859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First results obtained in France with the latest model of the Fresenius cell separator: AS 104.
    Coffe C; Couteret Y; Devillers M; Fest T; Hervé P; Kieffer Y; Lamy B; Masse M; Morel P; Pouthier-Stein F
    Transfus Sci; 1993 Jan; 14(1):51-5. PubMed ID: 10148313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the side effects and donor safety in preparatory cell collection using the cell separators CS 3,000 and V 50].
    Taborski U; Müller N
    Infusionstherapie; 1989 Aug; 16(4):186-8. PubMed ID: 2807566
    [No Abstract]   [Full Text] [Related]  

  • 14. [Single needle results with A-201 and AS-104 cell separators].
    Moog R
    Beitr Infusionsther; 1993; 31():104-6. PubMed ID: 7693236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of thrombocyte concentrates of the cell separator AS 104 with preparations of the cell separator CS 3000 (Fenwal)].
    Aulmann HM; Müller R; Zaky M; Avenarius HJ; Stangel W
    Beitr Infusionsther; 1990; 26():127-30. PubMed ID: 1703811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimizing cell separation with the Cell Separator AS-106].
    Kretschmer V; Rossa C
    Beitr Infusionsther; 1991; 28():188-94. PubMed ID: 1725617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor hemapheresis in France at the start of 1992.
    Coffe C; Norol F
    Transfus Sci; 1993 Apr; 14(2):163-4. PubMed ID: 10150147
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychophysiological thrombocyte changes in cell-separator donors].
    Aulmann HM; Baltrusch HJ; Stangel W; Waltz EM
    Beitr Infusionther Klin Ernahr; 1987; 18():227-9. PubMed ID: 3439979
    [No Abstract]   [Full Text] [Related]  

  • 19. [18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)].
    Zeiler T; Zingsem J; Weisbach V; Zimmermann R; Wittmann G; Eckstein R
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):91-5. PubMed ID: 8019115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In-line leukocyte depletion ov thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():110-3. PubMed ID: 9417333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.